Dr. Kyle Koski is a biological and cosmetic dentist, Co-Founder of the Institute of Cellular Dentistry (ICD), and a leading voice in the movement reconnecting oral biology with systemic and cellular medicine. Based in Cleveland, Ohio, his clinical practice focuses on full-mouth rehabilitation, airway and sleep dentistry, periodontal regeneration, biological surgery, and advanced healing protocols utilizing PRF, photobiomodulation, ozone therapy, peptides, exosomes, laser therapy, and oral microbiome diagnostics. Dr. Koski serves as an educator at PRFedu, where he trains clinicians in regenerative and facial aesthetic procedures using platelet-rich fibrin and biologic therapies. Through ICD, he co-created the most comprehensive integrated platform designed to merge dentistry and medicine at a clinical level — providing dentists with education, peptide therapy access, diagnostics, nutraceuticals, pharmacy integration, medical consultations, and physician collaboration across all 50 states. A former collegiate athlete, Dr. Koski approaches patient care through the lens of performance, systems biology, and cellular signaling — believing the body is always communicating, if clinicians are trained to listen.
Kyle Koski
Continue exploring related topics.
VIEW ALLEfficient Generation of Pancreatic Progenitor Cells from Induced Pluripotent Stem Cells Derived from a Non-Invasive and Accessible Tissue Source—The Plucked Hair Follicle
Dr. Seeds reviews how cryopreserved hair follicles may offer a simpler, non-invasive source for future stem cell research and pancreatic cell development. (Article Link)
Dr. Seeds’ Office Hours – Episode 095
1. Sjögren’s, POTS, Mold, Biofilms & Lumbrokinase (0:45)
2. PMDD, Allopregnanolone & Mitochondrial Efficiency (7:28)
3. Retatrutide, Glucagon & Metabolic Flexibility (20:01)
Cellular Optimization for EDS Surgical Support
Dr. Seeds reviews peptide and supplemental considerations for cellular optimization in an EDS patient preparing for orthopedic surgery. (Question Link)
The Phosphatidylcholine Pathway
Dr. Seeds expands on Journal Club Episode 92 to explore the role of phosphatidylcholine in lipid metabolism, methylation, and mitochondrial integrity during aging. He also highlights how estrogen loss may impact this pathway, especially in pre- and post-menopausal women.
Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)